Validation of aseptic processes is essential to ensuring the successful end result for manufacturers – a safe, effective finished product. However, the process starts long before that. Active ingredients and sterile bulk material must achieve the appropriate level of sterility assurance. This course will provide an in-depth overview of the requirements for cGMP-compliant aseptic process validation. This includes a detailed summary and analysis of mandates and guidance from several entities, including the US Food and Drug Administration (FDA), the Pharmaceutical Inspection Co-operation Scheme (PICs), and the European Union (EU). This interactive session will highlight industry best practices, and discuss common errors and deficiencies.
Finally, this course will discuss prospective, concurrent, and retrospective validation, plus the role of revalidation.
At the completion of this course, attendees will be able to:
Operations employees participating in manufacturing, quality control testing, and validation as part of their job function will find this course highly beneficial. This includes employees in the following functions:
Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.
Utilizing strategic thinking, risk based approaches, and Lean principles, she has demonstrated success in steering and managing complex projects within the pharmaceutical and medical device industries.